BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 16098445)

  • 1. A randomized trial comparing 1 mg of oral vitamin K with no treatment in the management of warfarin-associated coagulopathy in patients with mechanical heart valves.
    Ageno W; Garcia D; Silingardi M; Galli M; Crowther M
    J Am Coll Cardiol; 2005 Aug; 46(4):732-3. PubMed ID: 16098445
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the efficacy and safety profiles of intravenous vitamin K and fresh frozen plasma as treatment of warfarin-related over-anticoagulation in patients with mechanical heart valves.
    Yiu KH; Siu CW; Jim MH; Tse HF; Fan K; Chau MC; Chow WH
    Am J Cardiol; 2006 Feb; 97(3):409-11. PubMed ID: 16442406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low dose oral vitamin K to reverse acenocoumarol-induced coagulopathy: a randomized controlled trial.
    Ageno W; Crowther M; Steidl L; Ultori C; Mera V; Dentali F; Squizzato A; Marchesi C; Venco A
    Thromb Haemost; 2002 Jul; 88(1):48-51. PubMed ID: 12152676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of warfarin-associated coagulopathy with vitamin K.
    Patriquin C; Crowther M
    Expert Rev Hematol; 2011 Dec; 4(6):657-65; quiz 666-7. PubMed ID: 22077529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin K for warfarin-associated coagulopathy.
    Witt MD; Patel R; Tillman DJ; Wilkinson DS
    Lancet; 2001 Mar; 357(9257):718. PubMed ID: 11247582
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial.
    Crowther MA; Douketis JD; Schnurr T; Steidl L; Mera V; Ultori C; Venco A; Ageno W
    Ann Intern Med; 2002 Aug; 137(4):251-4. PubMed ID: 12186515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of warfarin: case-based practice recommendations.
    Garcia DA; Crowther MA
    Circulation; 2012 Jun; 125(23):2944-7. PubMed ID: 22689931
    [No Abstract]   [Full Text] [Related]  

  • 8. Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10.
    Gunther KE; Conway G; Leibach L; Crowther MA
    Thromb Res; 2004; 113(3-4):205-9. PubMed ID: 15140584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Summaries for patients. Vitamin K reverses overanticoagulation with warfarin more quickly when given by mouth than by injection.
    Ann Intern Med; 2002 Aug; 137(4):I39. PubMed ID: 12186539
    [No Abstract]   [Full Text] [Related]  

  • 10. Poor correlation of supratherapeutic international normalised ratio and vitamin K-dependent procoagulant factor levels during warfarin therapy.
    Sarode R; Rawal A; Lee R; Shen YM; Frenkel EP
    Br J Haematol; 2006 Mar; 132(5):604-7. PubMed ID: 16445834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, placebo-controlled trial of orally administered vitamin K1 for warfarin-associated coagulopathy in Chinese patients with mechanical heart valves.
    Zhang H; Li M; Ao XL; Dong YJ; Dong L
    Eur J Clin Pharmacol; 2021 Sep; 77(9):1333-1339. PubMed ID: 33783553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of vitamin K antagonist-associated coagulopathy: a survey of current practice.
    Neal M; Crowther M; Douketis J; Verhovsek M; Stidley C; Garcia D
    Thromb Res; 2008; 122(6):864-6. PubMed ID: 18678398
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of anticoagulation in patients with prosthetic heart valves undergoing oral and maxillofacial operations.
    Webster K; Wilde J
    Br J Oral Maxillofac Surg; 2000 Apr; 38(2):124-6. PubMed ID: 10864707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical management of coagulopathy associated with warfarin.
    Garcia D; Crowther MA; Ageno W
    BMJ; 2010 Apr; 340():c1813. PubMed ID: 20404060
    [No Abstract]   [Full Text] [Related]  

  • 15. A promising new alternative for the rapid reversal of warfarin coagulopathy in traumatic intracranial hemorrhage.
    Safaoui MN; Aazami R; Hotz H; Wilson MT; Margulies DR
    Am J Surg; 2009 Jun; 197(6):785-90. PubMed ID: 18722586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary vitamin K guidance: an effective strategy for stable control of oral anticoagulation?
    Booth SL
    Nutr Rev; 2010 Mar; 68(3):178-81. PubMed ID: 20384848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herbal drug curbicin and anticoagulant effect with and without warfarin: possibly related to the vitamin E component.
    Yue QY; Jansson K
    J Am Geriatr Soc; 2001 Jun; 49(6):838. PubMed ID: 11454132
    [No Abstract]   [Full Text] [Related]  

  • 18. Monitoring warfarin therapy.
    Beanland DR; Dorsey DA
    Am Fam Physician; 1999 Sep; 60(3):764, 766. PubMed ID: 10498107
    [No Abstract]   [Full Text] [Related]  

  • 19. Surgical delay in acute admissions on warfarin: are we doing enough?
    Tharmarajah P
    Int J Clin Pract; 2007 Jul; 61(7):1233. PubMed ID: 17577302
    [No Abstract]   [Full Text] [Related]  

  • 20. Warfarin hypersensitivity due to gluten-sensitive enteropathy: a case study.
    Kwolek S; Deming P
    Clin Lab Sci; 2012; 25(2):78-80. PubMed ID: 22693776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.